Moore Capital Management’s Ibere Pharmaceuticals IBER Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-300,000
| Closed | -$3.03M | – | 611 |
|
|
2022
Q4 | $3.03M | Hold |
300,000
| – | – | 0.07% | 201 |
|
|
2022
Q3 | $2.97M | Hold |
300,000
| – | – | 0.07% | 274 |
|
|
2022
Q2 | $2.94M | Hold |
300,000
| – | – | 0.08% | 253 |
|
|
2022
Q1 | $2.94M | Hold |
300,000
| – | – | 0.07% | 284 |
|
|
2021
Q4 | $2.92M | Hold |
300,000
| – | – | 0.06% | 313 |
|
|
2021
Q3 | $2.91M | Hold |
300,000
| – | – | 0.04% | 356 |
|
|
2021
Q2 | $2.9M | Buy |
+300,000
| New | +$2.9M | 0.04% | 361 |
|